Basic Information
Apath is a privately-held technology licensing company engaged in the commercial application of virology and viral genetics, assisting pharmaceutical companies in discovering and developing therapeutic products for viral infections. Apath’s current research focus is on the hepatitis C virus (HCV). The company also works with other human pathogenic RNA viruses, including influenza viruses, respiratory syncytial virus (RSV), and hemorrhagic fever viruses.